Documents

Briefs, oral arguments, agency decisions and the Federal Register.

5,436 results

0.34s

  • Permanent Listing of Color Additive Lakes

    Federal Register · Proposed Rule · Mar 4, 1996

    Paperwork Reduction Act XII. Comments XIII. References I. … until the period for filing objections is over.

    61 FR 8372Health and Human Services DepartmentFood and Drug Administration
  • Advisory Committee; Notice of Meeting

    Federal Register · Notice · May 15, 1997

    brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time required to make their comments … The Federal Advisory Committee Act (FACA) (5 U.S.C. app. 2, 10(d)), permits such closed advisory committee meetings in certain circumstances.

    62 FR 26804Health and Human Services DepartmentFood and Drug Administration
  • Advisory Committee; Notice of Meeting

    Federal Register · Notice · May 7, 1996

    that the 1 hour time limit for an open public hearing represents a minimum rather than a maximum time [[Page 20528]] for public participation, and an open public hearing may last for whatever longer period … The Federal Advisory Committee Act (FACA) (5 U.S.C. app. 2, 10(d)), permits such closed advisory committee meetings in certain circumstances.

    61 FR 20527Health and Human Services DepartmentFood and Drug Administration
  • Advisory Committee; Notice of Meeting

    Federal Register · Notice · Apr 18, 1997

    brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time required to make their comments … The Federal Advisory Committee Act (FACA) (5 U.S.C. app. 2, 10(d)), permits such closed advisory committee meetings in certain circumstances.

    62 FR 19120Health and Human Services DepartmentFood and Drug Administration
  • Medical Devices; Classification/Reclassification of Immunohistochemistry Reagents and Kits

    Federal Register · Rule · Jun 3, 1998

    One comment asked FDA to discuss with the Health Care Financing Administration (HCFA) and announce the Medicare reimbursement status of: (1) IHC reagents in the interim period while manufacturers prepared … Regulatory Enforcement Fairness Act of 1966 (Pub.

    63 FR 30132Health and Human Services DepartmentFood and Drug Administration
  • Amendments to Sterility Test Requirements for Biological Products

    Federal Register · Proposed Rule · Jun 21, 2011

    This verification activity may be necessary periodically or each time a sample is tested, depending upon the test method used. … Reduction Act of 1995 (the PRA) (44 U.S.C. 3501-3520).

    76 FR 36019Health and Human Services DepartmentFood and Drug Administration
  • Center for Devices and Radiological Health Ethylene Oxide Sterilization Master File Pilot Program

    Federal Register · Notice · Nov 26, 2019

    The EtO Pilot Program participants may comment on and discuss their experiences with the Center. II. … Paperwork Reduction Act of 1995 This notice refers to previously approved collections of information found in FDA regulations.

    84 FR 65162Health and Human Services DepartmentFood and Drug Administration
  • Advisory Committee; Notice of Meeting

    Federal Register · Notice · May 22, 1997

    brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time required to make their comments … The Federal Advisory Committee Act (FACA) (5 U.S.C. app. 2, 10(d)), permits such closed advisory committee meetings in certain circumstances.

    62 FR 28053Health and Human Services DepartmentFood and Drug Administration
  • Advisory Committee; Notice of Meeting

    Federal Register · Notice · Apr 23, 1997

    brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time required to make their comments … The Federal Advisory Committee Act (FACA) (5 U.S.C. app. 2, 10(d)), permits such closed advisory committee meetings in certain circumstances.

    62 FR 19764Health and Human Services DepartmentFood and Drug Administration
  • Advisory Committee; Notice of Meeting

    Federal Register · Notice · Apr 21, 1997

    brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time required to make their comments … The Federal Advisory Committee Act (FACA) (5 U.S.C. app. 2, 10(d)), permits such closed advisory committee meetings in certain circumstances.

    62 FR 19325Health and Human Services DepartmentFood and Drug Administration
  • Annual Comprehensive List of Guidance Documents at the Food and Drug Administration

    Federal Register · Notice · Oct 24, 2001

    DATES: We welcome general comments on this list and on agency guidance documents at any time. … PB96-127287) or via Internet at: www.fda.gov/ora/inspect—;ref/igs/iglist.html Guide to Inspections of Validation of Cleaning Processes July 1993 Do Do (NTIS Order No.

    66 FR 53836Health and Human Services DepartmentFood and Drug Administration
  • Draft Compliance Policy Guide Sec. 555.320 Listeria monocytogenes; Notice of Public Meeting

    Federal Register · Notice · Feb 7, 2008

    Stakeholders will have an opportunity to ask questions about the draft CPG and provide oral comments on the draft CPG. … Under section 402(a)(1) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 342(a)(1)), a food shall be deemed to be adulterated if it bears or contains any poisonous or deleterious substance

    73 FR 7298Health and Human Services DepartmentFood and Drug Administration
  • Prescription Drug User Fee Rates for Fiscal Year 2021

    Federal Register · Notice · Aug 3, 2020

    This iterative, continuous improvement approach to the CPA methodology was recommended by the independent evaluation and in the public comments. … As table 12 shows, the average number of fee-paying FAEs received annually in the most recent 3-year period is 77 FAEs.

    85 FR 46651Health and Human Services DepartmentFood and Drug Administration
  • Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-The-Counter Human Use; Final Rule for Professional Labeling of Aspirin, Buffered Aspirin, and Aspirin in Combination With Antacid Drug Products

    Federal Register · Rule · Oct 23, 1998

    The Agency's Conclusions on the Comments A. Comments to the TFM 1. … Section 502(f) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 352(f)) states that a drug shall be deemed misbranded: ``Unless its labeling bears (1) adequate directions for use; and (

    63 FR 56802Health and Human Services DepartmentFood and Drug Administration
  • Advisory Committee; Notice of Meeting

    Federal Register · Notice · May 8, 1996

    brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time required to make their comments … This notice is issued under section 10(a)(1) and (2) of the Federal Advisory Committee Act (5 U.S.C. app. 2), and FDA's regulations (21 CFR part 14) on advisory committees.

    61 FR 20831Health and Human Services DepartmentFood and Drug Administration
  • Funding Opportunity Title: Food Safety Task Force Conference Announcement Type: New Request for Applications Funding Opportunity Number: RFA-FDA-ORA-2005-3 Catalog of Federal Domestic Assistance (CFDA) Number(s):93-103

    Federal Register · Notice · May 3, 2005

    Meetings covered by this notice will be supported under sections 1701-1706 (42 USC 300u-300u-5) of the Public Health Service Act. … The FDA does not guarantee availability to accommodate or explain SPOC comments that are received after the 60-day cut-off.

    70 FR 22889Health and Human Services DepartmentFood and Drug Administration
  • Food Additives Permitted for Direct Addition to Food for Human Consumption; Vitamin D3 in Yogurt and Other Cultured Dairy Products Fermented With Lactobacillus delbrueckii, Subspecies bulgaricus, and Streptococcus thermophilus

    Federal Register · Rule · Sep 4, 2025

    We have not received any new information or comments regarding this claim of categorical exclusion. … Section 301(ll) of the Federal Food, Drug, and Cosmetic Act Our review of this petition was limited to section 409 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 348).

    90 FR 42699Health and Human Services DepartmentFood and Drug Administration
  • Regulations Regarding “Intended Uses”

    Federal Register · Proposed Rule · Sep 23, 2020

    Please note that late, untimely filed comments will not be considered. Electronic comments must be submitted on or before October 23, 2020. … Benefits, Costs, and Distributional Effects of Proposed Rule Category Primary estimate Low estimate High estimate Units Year dollars Discount rate (percent) Period

    85 FR 59718Health and Human Services DepartmentFood and Drug Administration
  • International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; AB-FUBINACA; 5F-AMB-PINACA; 5F-MDMB-PICA; 4-F-MDMB-BINACA; 4-CMC; N-ethylhexedrone; alpha-PHP; DOC; Crotonyl Fentanyl; Valeryl Fentanyl; Flualprazolam and Etizolam; Request for Comments

    Federal Register · Notice · Dec 31, 2019

    This notice is issued under the Controlled Substances Act (CSA). DATES: Submit either electronic or written comments by January 30, 2020. … The short time period for the submission of comments is needed to ensure that Health and Human Services (HHS) may, in a timely fashion, carry out the required action and be responsive to the United Nations

    84 FR 72370Health and Human Services DepartmentFood and Drug Administration
  • Listing of Color Additives Exempt from Certification; Canthaxanthin

    Federal Register · Rule · Mar 27, 1998

    The petition was filed under section 721(d) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 379e(d)). II. … FDA received one comment on the petition. This comment endorsed the petitioned use of canthaxanthin. III. Stability FDA finds that canthaxanthin is relatively unstable.

    63 FR 14814Health and Human Services DepartmentFood and Drug Administration

Ask Donna what matters in the record.

She can read the source against your case and show you exactly where the answer came from.

Ask Donna

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.